Cardiovascular Diseases

Recombinant Shingles Vaccine Linked to Reduced Cardiovascular Risk

The recombinant shingles vaccine was associated with a 9% reduction in overall cardiovascular burden over 7 years among adults aged 60 years or older, based on a natural experiment that reduced confounding from existing studies comparing vaccinated and unvaccinated individuals. Researchers compared adults vaccinated immediately before versus immediately after the rapid US transition from the live attenuated to the recombinant shingles vaccine. The recombinant vaccine was associated with a 10% lower burden of ischemic heart disease and a 12% lower burden of heart failure in both sexes, as well as a 12% lower burden of ischemic stroke among men; atrial fibrillation was also associated with a 7% lower burden. The associations weakened over time and were not observed for other cardiac, peripheral, or cerebrovascular outcomes. These findings support further clinical trials and mechanistic studies to determine whether shingles vaccination may have cardioprotective effects. Source: https://www.nature.com/

hyangiu

Recent Posts

Modified Position Management Improved Outcomes in Heart Failure Patients

In a single-center, parallel-group, randomized superiority trial of 150 Chinese hospitalized heart failure patients with…

2 hours ago

Proteomic Study Identified Novel Ischemic Stroke Risk Factors

A proteomic and genomic investigation combining the ARIC and CHS cohorts has identified 44 proteins…

2 hours ago

T2D Linked to Higher Alzheimer’s Risk

People with type 2 diabetes (T2D) develop Alzheimer's disease (AD) at a rate of about…

3 hours ago

ACS Updates Prostate Cancer Screening Guidance

The American Cancer Society (ACS) concludes that the benefits of PSA-based screening for prostate cancer…

4 days ago

Proton Pump Inhibitor Use Linked to Dementia Risk in Older Adults

Proton pump inhibitor (PPI) use was modestly associated with incident dementia in older adults (pooled…

5 days ago

Long-Term Outcomes of Invasive vs Conservative Management in Stable Coronary Disease: Consistent Evidence From Extended Follow-Up Trials

Extended follow-up of three major trials consistently shows that an initial invasive strategy does not…

6 days ago

This website uses cookies.